MATERNUS-KLINIKEN AKTIENGESELLSCHAFT

(MAK)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2016 2017 2018 2019
Capitalization1 26,449,039,442,8
Enterprise Value (EV)1 73,690,7113133
P/E ratio 23,9x-33,6x-25,0x-4,17x
Yield ----
Capitalization / Revenue 0,21x0,39x0,32x0,34x
EV / Revenue 0,59x0,71x0,91x1,07x
EV / EBITDA 6,73x10,2x20,2x-149x
Price to Book -11,3x-12,8x-7,27x-2,70x
Nbr of stocks (in thousands) 20 97020 97020 97020 970
Reference price (EUR) 1,262,341,882,04
Announcement Date 05/01/201804/30/201904/30/202004/30/2021
1 EUR in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2016 2017 2018 2019
Net sales1 124127124124
EBITDA1 10,98,935,62-0,89
Operating profit (EBIT)1 5,793,920,02-4,36
Operating Margin 4,67%3,09%0,02%-3,50%
Pre-Tax Profit (EBT)1 0,130,86-2,82-11,0
Net income1 1,10-1,46-1,58-10,3
Net margin 0,89%-1,15%-1,27%-8,24%
EPS2 0,05-0,07-0,08-0,49
Dividend per Share ----
Announcement Date 05/01/201804/30/201904/30/202004/30/2021
1 EUR in Million
2 EUR
Balance Sheet Analysis
Fiscal Period: December 2016 2017 2018 2019
Net Debt1 47,241,774,090,2
Net Cash position1 ----
Leverage (Debt / EBITDA) 4,31x4,67x13,2x-101x
Free Cash Flow1 6,416,95-3,9935,8
ROE (Net Profit / Equities) 394%-98,4%124%
Shareholders' equity1 0,28--1,60-8,26
ROA (Net Profit / Asset) 3,24%2,23%0,01%-1,86%
Assets1 34,1-65,2-12 500552
Book Value Per Share2 -0,11-0,18-0,26-0,76
Cash Flow per Share2 0,330,280,090,03
Capex1 0,720,980,920,70
Capex / Sales 0,58%0,77%0,74%0,56%
Announcement Date 05/01/201804/30/201904/30/202004/30/2021
1 EUR in Million
2 EUR
Key data
Capitalization (EUR) 69 201 000
Capitalization (USD) 72 031 852
Number of employees 1 618
Free-Float 18,3%
Free-Float capitalization (EUR) 12 664 641
Free-Float capitalization (USD) 13 182 722
Avg. Exchange 20 sessions () 2 900
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 0,00%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA